Data / Form D filings / SunBird Bio, Inc.
SunBird Bio, Inc.: Form D filings
SunBird Bio, Inc., a biotechnology company in Cambridge, MA, filed 5 Form D notices with the SEC between 2018 and 2023. The latest, on May 12, 2023, reports $23.2 million sold of a $23.2 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 35 CAMBRIDGEPARK DR., SUITE 100, Cambridge, MA, 02140
- Phone
- (617) 863-3636
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1749272
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2023 | New notice | $23,239,099 | $23,239,099 | 10 | Apr 27, 2023 | sec.gov | |
| Dec 17, 2021 | New notice | $17,999,987 | $17,999,987 | 12 | Dec 2, 2021 | sec.gov | |
| Jul 1, 2021 | Amendment | $46,699,979 | $46,699,979 | 19 | May 29, 2020 | sec.gov | |
| Jun 12, 2020 | New notice | $45,000,000 | $26,106,974 | $18,893,026 | 18 | May 29, 2020 | sec.gov |
| Aug 6, 2018 | New notice | $30,087,333 | $26,087,335 | $3,999,998 | 17 | Jul 20, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| ALEXANDRA CANTLEY | Director | |
| STANLEY LAPIDUS | Director | |
| JOHN MCDONOUGH | Director | |
| YINGMIN WANG | Director | |
| HUILIN SHAO | Director | |
| STEVE KAFKA | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of May 8, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SunBird Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.